Literature DB >> 3156705

Paget's disease of bone: clinical features and treatment.

A J Zajac, P E Phillips.   

Abstract

Paget's disease of bone is often discovered incidentally, but can have extensive metabolic and local mechanical complications. Treatment is not required for all patients and should only be undertaken for certain indications, and with a clear understanding of the three types of drugs available. Bone pain unmanageable with analgesics and pathologic fractures are the most common indications, while neurologic symptoms, hypercalcemia and congestive heart failure are less frequent ones. Calcitonin or mithramycin is used for the more urgent indications, and calcitonin or the diphosphonate, etidronate sodium (EHDP), for the more chronic ones. The drugs are generally efficacious and well tolerated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156705

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  6 in total

1.  Osteoclast-derived IGF1 is required for pagetic lesion formation in vivo.

Authors:  Kazuaki Miyagawa; Yasuhisa Ohata; Jesus Delgado-Calle; Jumpei Teramachi; Hua Zhou; David D Dempster; Mark A Subler; Jolene J Windle; John M Chirgwin; G David Roodman; Noriyoshi Kurihara
Journal:  JCI Insight       Date:  2020-03-26

2.  Measles virus nucleocapsid protein increases osteoblast differentiation in Paget's disease.

Authors:  Jumpei Teramachi; Yuki Nagata; Khalid Mohammad; Yuji Inagaki; Yasuhisa Ohata; Theresa Guise; Laëtitia Michou; Jacques P Brown; Jolene J Windle; Noriyoshi Kurihara; G David Roodman
Journal:  J Clin Invest       Date:  2016-02-15       Impact factor: 14.808

3.  CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts.

Authors:  Matthew B Greenblatt; Kwang Hwan Park; Hwanhee Oh; Jung-Min Kim; Dong Yeon Shin; Jae Myun Lee; Jin Woo Lee; Anju Singh; Ki-young Lee; Dorothy Hu; Changchun Xiao; Julia F Charles; Josef M Penninger; Sutada Lotinun; Roland Baron; Sankar Ghosh; Jae-Hyuck Shim
Journal:  J Exp Med       Date:  2015-07-20       Impact factor: 14.307

Review 4.  Pathobiology of Paget's Disease of Bone.

Authors:  Deborah L Galson; G David Roodman
Journal:  J Bone Metab       Date:  2014-05-31

5.  The crucial role of divalent metal ions in the DNA-acting efficacy and inhibition of the transcription of dimeric chromomycin A3.

Authors:  Chun-Wei Hsu; Show-Mei Chuang; Wen-Ling Wu; Ming-Hon Hou
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

6.  Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease.

Authors:  Yuki Nagata; Kazuaki Miyagawa; Yasuhisa Ohata; Daniela N Petrusca; Gabriel M Pagnotti; Khalid S Mohammad; Theresa A Guise; Jolene J Windle; G David Roodman; Noriyoshi Kurihara
Journal:  J Cell Biochem       Date:  2020-10-27       Impact factor: 4.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.